Some researchers say a new approach, which suppresses a particular part of the immune system rather than amplifying it, could be available in the next five yearsAutoimmune diseases affect as many as 800 million people around the world – around one in 10 of us. From multiple sclerosis and lupus to type one diabetes and rheumatoid arthritis, these conditions all share a common trait: the body’s own immune system turns against itself.Current treatments aim to suppress that response, but dialing down the entire immune system comes at a steep cost: it leaves patients vulnerable to other illnesses and often requires daily, invasive care. Continue reading...